Canaan XI L.P. 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-02 4:15 pm Sale |
2022-10-31 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
Canaan XI L.P. | 2,548,403 3.500% |
-2,200,000 (-46.33%) |
Filing |
| 2022-10-19 5:29 pm Sale |
2022-10-17 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
Canaan XI L.P. | 4,748,403 6.500% |
-2,215,898 (-31.82%) |
Filing |
| 2022-09-22 11:06 am Sale |
2022-09-21 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
Canaan XI L.P. | 6,964,301 9.500% |
-2,338,998 (-25.14%) |
Filing |
| 2022-09-19 2:02 pm Sale |
2022-09-13 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
Canaan XI L.P. | 9,303,299 12.700% |
-360,346 (-3.73%) |
Filing |
| 2021-12-22 4:39 pm Sale |
2021-12-21 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
Canaan XI L.P. | 9,663,645 15.600% |
-1,072,000 (-9.99%) |
Filing |
| 2021-06-10 4:13 pm Purchase |
2021-06-01 | 13D | Day One Biopharmaceuticals, Inc. DAWN |
Canaan XI L.P. | 10,735,645 17.300% |
10,735,645 (New Position) |
Filing |